| For: | Jiang C, Zhang ZH, Li JX. Consideration on immunotherapy of liver metastases of malignant tumors. World J Gastrointest Surg 2024; 16(8): 2374-2381 [PMID: 39220060 DOI: 10.4240/wjgs.v16.i8.2374] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v16/i8/2374.htm |
| Number | Citing Articles |
| 1 |
Yi Zhu, Xiao Qi, Senmiao Ni, Wenting Qiu, Mengkai Chen. First-Line Serplulimab versus Other Anti-PD-1/PD-L1 Antibodies Plus Chemotherapy for Esophageal Squamous Cell Carcinoma: A Systematic Review with Benefit-Risk Assessment via Matching-Adjusted Indirect Comparison. Biologics: Targets and Therapy 2026; : 1 doi: 10.2147/BTT.S602654
|
| 2 |
Noura A A Ebrahim, Thoraya A Farghaly, Ahmed Abdo El-Sherif, Ahmed M Fahmy, Moamen O Othman, Neveen S Tahoun, Omnia Mohamed Korany, Aya Arafat, Reham Oreaba, Soliman M A Soliman. Clinicopathological insights and management of liver metastases: Current advances and future perspectives. World Journal of Hepatology 2025; 17(10): 110026 doi: 10.4254/wjh.v17.i10.110026
|
| 3 |
Lin-Feng Guo, Guan-Zhong Lu, Zhen-Zhen Lu, Yi-Feng Yu, San-Gang Wu. Patterns of failure and prognosis in nasopharyngeal carcinoma according to Epstein-Barr virus DNA status. Infectious Agents and Cancer 2025; 20(1) doi: 10.1186/s13027-024-00631-1
|
| 4 |
Wenkai Kang, Zhiqiang Zhang, Wentao Li, Qingyuan Zhang, Ningning Li, Youheng Jiang, Junjing Zhang, Yulong He. Breaching the immune-cold barrier in pMMR/MSS metastatic colorectal cancer: emerging strategies beyond standard care. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1773002
|
